Literature DB >> 32196097

Assessing Ganglion Cell Layer Topography in Human Albinism Using Optical Coherence Tomography.

Erica N Woertz1, Bisola S Omoba1, Taylor M Dunn1, Stephanie J Chiu1, Sina Farsiu1,1, Sasha Strul1, C Gail Summers1, Arlene V Drack1, Joseph Carroll1,1.   

Abstract

Purpose: To test whether ganglion cell layer (GCL) and inner plexiform layer (IPL) topography is altered in albinism.
Methods: Optical coherence tomography scans were analyzed in 30 participants with albinism and 25 control participants. Horizontal and vertical line scans were acquired at the fovea, then strip registered and averaged. The Duke Optical Coherence Tomography Retinal Analysis Program was used to automatically segment the combined GCL and IPL and total retinal thickness, followed by program-assisted manual segmentation of the boundary between the GCL and IPL. Layer thickness and area under the curve (AUC) were calculated within 2.5 mm of the fovea. Nasal-temporal and superior-inferior asymmetry were calculated as an AUC ratio in each quadrant.
Results: GCL and IPL topography varied between participants. The summed AUC in all quadrants was similar between groups for both the GCL (P = 0.84) and IPL (P = 0.08). Both groups showed nasal-temporal asymmetry in the GCL, but only participants with albinism had nasal-temporal asymmetry in the IPL. Nasal-temporal asymmetry was greater in albinism for both the GCL (P < 0.0001) and the IPL (P = 0.0006). The GCL usually comprised a greater percentage of the combined GCL and IPL in controls than in albinism. Conclusions: The GCL and IPL have greater structural variability than previously reported. GCL and IPL topography are significantly altered in albinism, which suggests differences in the spatial distribution of retinal ganglion cells. This finding provides insight into foveal development and structure-function relationships in foveal hypoplasia.

Entities:  

Year:  2020        PMID: 32196097     DOI: 10.1167/iovs.61.3.36

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

1.  Retinal alterations in patients with Lafora disease.

Authors:  Heather Heitkotter; Rachel E Linderman; Jenna A Cava; Erica N Woertz; Rebecca R Mastey; Phyllis Summerfelt; Toco Y Chui; Richard B Rosen; Emily J Patterson; Ajoy Vincent; Joseph Carroll; Berge A Minassian
Journal:  Am J Ophthalmol Case Rep       Date:  2021-06-15

Review 2.  Promises and pitfalls of evaluating photoreceptor-based retinal disease with adaptive optics scanning light ophthalmoscopy (AOSLO).

Authors:  Niamh Wynne; Joseph Carroll; Jacque L Duncan
Journal:  Prog Retin Eye Res       Date:  2020-11-06       Impact factor: 19.704

3.  The Influence of Axial Length Upon the Retinal Ganglion Cell Layer of the Human Eye.

Authors:  Min Chen; Jill Nofziger; Ritobrato Datta; James C Gee; Jessica Morgan; Geoffrey K Aguirre
Journal:  Transl Vis Sci Technol       Date:  2020-12-07       Impact factor: 3.283

4.  Characterization of Retinal Thickness in Individuals with Albinism: Baseline Data for a Black South African Population.

Authors:  Ethan Pillay; Thiroshnee Naidoo; Khadija Asmal; Lilitha Maliwa; Sinenhlanhla Mchunua; Diane Beverly van Staden; Nishanee Rampersad
Journal:  Clin Optom (Auckl)       Date:  2021-01-20

5.  Optical Coherence Tomography as a Biomarker for Differential Diagnostics in Nystagmus: Ganglion Cell Layer Thickness Ratio.

Authors:  Khaldoon O Al-Nosairy; Elisabeth V Quanz; Julia Biermann; Michael B Hoffmann
Journal:  J Clin Med       Date:  2022-08-23       Impact factor: 4.964

6.  Examining Whether AOSLO-Based Foveal Cone Metrics in Achromatopsia and Albinism Are Representative of Foveal Cone Structure.

Authors:  Katie M Litts; Erica N Woertz; Niamh Wynne; Brian P Brooks; Alicia Chacon; Thomas B Connor; Deborah Costakos; Alina Dumitrescu; Arlene V Drack; Gerald A Fishman; William W Hauswirth; Christine N Kay; Byron L Lam; Michel Michaelides; Mark E Pennesi; Kimberly E Stepien; Sasha Strul; C Gail Summers; Joseph Carroll
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.048

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.